Summary
Dendritic cells (DCs) are potent antigen presenting cells and play critical role in T cell-mediated immunity. DCs have been shown to induce strong anti-tumor responses both in vitro and in vivo. Their efficacies in tumor therapy are being investigated in clinical trials. Previous evidence has shown that these DCs enhance the cytotoxicity of NK cells. We generated NK-like T cells (CD3+CD56+), a novel type of effector cells differentiated from normal lymphocyte, which is now being used for adoptive immunotherapy in clinical trials. This study aimed to elucidate the effects of NK-like T cells after co-culturing with DCs against tumor cells. The result revealed that tumor-derived RNA-pulsed DCs can enhance the immune responses of NK-like T cells against glioblastoma multiforme cell line but these effector cells did not appear to have the cytotoxic effect against normal cells (human umbilical vein endothelial cells (HUVEC) and fibroblasts) in vitro. This study may be beneficial for the development of new immunologic effector cells for using in adoptive immunotherapy for glioblastoma multiforme in the future.
Similar content being viewed by others
References
MD Walker E Alexander WE Hunt (1978) ArticleTitleEvaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: a cooperative trial J Neurosurg 49 333–343 Occurrence Handle355604
MD Walker SB Green DP Byar EJ Alexander U Batzdorf WE Hunt CS MacCarty MS Mahaley JJ Mealy G Owens JI Ransahoff JT Robertson WR Shapiro KRJ Smith CB Wilson TA Strike (1980) ArticleTitleRandomized comparisons of radiotherapy and nitrosureas for the treatment of malignant gliomas after surgery N Engl J Med 303 1323–1329 Occurrence Handle7001230
LM DeAngelis PC Burger SB Green JG Cairncross (1998) ArticleTitleMalignant glioma: who benefits from adjuvant chemotherapy? Ann Neurol 44 691–695 Occurrence Handle10.1002/ana.410440418 Occurrence Handle9778271
L Fong E Engleman (2000) ArticleTitleDendritic cells in cancer immunotherapy Ann Rev Immunol 18 767–811 Occurrence Handle10.1146/annurev.immunol.18.1.245
D Bell J Young J Banchereau (1999) ArticleTitleDendritic cells Adv Immunol 72 225–324
C Milazzo VL Reichardt MR Muller F Grunebach P Brossart (2003) ArticleTitleInduction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA Blood 101 997–982 Occurrence Handle10.1182/blood-2002-04-1273
A Heiser MA Maurice DR Yancey NZ Wu P Dahm SK Pruitt D Boczkowski SK Nair MS Ballo E Gilboa J Vieweg (2001) ArticleTitleInduction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA J Immunol 166 2953–2960 Occurrence Handle11207244
WE Schmitt MJ Stassar W Schmitt M Little B Cochlovius (2001) ArticleTitleIn vitro induction of a bladder cancer-specific T-cell response by mRNA-transfected dendritic cells J Cancer Res Clin Oncol 127 203–206 Occurrence Handle10.1007/s004320000201 Occurrence Handle11260867
DM Ashley B Faiola S Nair LP Hale DD Bigner E Gilboa (1997) ArticleTitleBone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors J Exp Med 186 1177–1182 Occurrence Handle10.1084/jem.186.7.1177 Occurrence Handle9314567
D Boczkowski SK Nair JH Nam HK Lyerly E Gilboa (2000) ArticleTitleInduction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells Cancer Res 60 1028–1034 Occurrence Handle10706120
GD Schmidt-Wolf RS Negrin IG Schmidt-Wolf (1997) ArticleTitleActivated T cells and cytokine-induced CD3+CD56+ killer cells Ann Hematol 74 51–56 Occurrence Handle10.1007/s002770050257 Occurrence Handle9063373
RE Schmidt C Murray JF Daley SF Schlossman J Ritz (1986) ArticleTitleA subset of natural killer cells in peripheral blood displays mature T cell phenotype J Exp Med 164 351–356 Occurrence Handle10.1084/jem.164.1.351 Occurrence Handle3088199
LL Lanier AM Le CI Civin MR Loken JH Phillips (1986) ArticleTitleThe relationship of CD 16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes J Immunol 136 4480–4486 Occurrence Handle3086432
JR Ortaldo RT Winkler-Pickett H Yagita HA Young (1991) ArticleTitleComparative studies of CD3+- and CD3+CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression Cell Immunol 136 486–495 Occurrence Handle10.1016/0008-8749(91)90369-M Occurrence Handle1714795
P Lu R Negrin (1994) ArticleTitleA novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with SCID J Immunol 153 1678–1696
MR Verneris M Kornacker V Mailander RS Negrin (2000) ArticleTitleResistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis Cancer Immunol Immunother 49 335–345 Occurrence Handle10.1007/s002620000111 Occurrence Handle10946816
C Hoyle CD Bangs P Chang O Kamel B Mehta RS Negrin (1998) ArticleTitleExpansion of Philadelphia chromosome-negative CD3+CD56+ cytotoxic cells from chronic myeloid leukemic patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice Blood 92 3318–3327 Occurrence Handle9787169
P Lefterova F Schakowski P Buttgereit C Scheffold D Huhn IG Schmidt-Wolf (2000) ArticleTitleExpansion of CD3+CD56+ cytotoxic cells from patients with chronic lymphocytic leukemia: in vitro efficacy Haematologica 104 72–79 Occurrence Handle10.1159/000039755
IG Schmidt-Wolf S Finke B Trojaneck A Denkena P Lefterova N Schwella HG Heuft G Prange M Korte M Takeya T Dorbic A Neubauer B Wittig D Huhn (1999) ArticleTitlePhase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma Br J Cancer 81 1009–1016 Occurrence Handle10.1038/sj.bjc.6690800 Occurrence Handle10576658
D Valteau-Couanet C Leboulaire K Maincent M Tournier O Hartmann J Benard F Beaujean C Boccaccio L Zitvogel E Angevin (2002) ArticleTitleDendritic cells for NK/LAK activation: rationale for multicellular immunotherapy in neuroblastoma patients Blood 100 2554–2561 Occurrence Handle10.1182/blood.V100.7.2554 Occurrence Handle12239169
A Marten S Renoth M Lilienfeld-Toal Particlevon P Buttgereit F Schakowski A Glasmacher T Sauerbruch IG Schmidt-Wolf (2001) ArticleTitleEnhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells Haematologica 86 1029–1037 Occurrence Handle11602408
C Ziske A Marten B Schottker P Buttgereit F Schakowski M Gorschluter A Rucker Particlevon C Scheffold N Chao T Sauerbruch IG Schmidt-Wolf (2001) ArticleTitleResistance of pancreatic carcinoma cells is reversed by coculturing NK-like T cells with dendritic cells pulsed with tumor-derived RNA and CA19–9 Mol Ther 3 54–60 Occurrence Handle10.1006/mthe.2000.0230 Occurrence Handle11162311
P Brossart F Grunebach G Stuhler VL Reichardt R Mohle L Kanz W Brugger (1998) ArticleTitleGeneration of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor Blood 92 4238–4247 Occurrence Handle9834229
IG Schmidt-Wolf P Lefterova V Johnston D Huhn KG Blume RS Negrin (1994) ArticleTitlePropagation of large numbers of T cells with natural killer cell markers Br J Haematol 87 453–458 Occurrence Handle7527643
CM Celluzzi JI Mayordomo WJ Storkus MT Lotze LD Falo SuffixJr. (1996) ArticleTitlePeptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity J Exp Med 183 283–287 Occurrence Handle10.1084/jem.183.1.283 Occurrence Handle8551233
A Porgador E Gliboa (1995) ArticleTitleBone marrow-generated dendritic cells pulsed with class I-restricted peptide are potent inducers of cytotoxic T lymphocytes J Exp Med 182 255–260 Occurrence Handle10.1084/jem.182.1.255 Occurrence Handle7540653
HT Ni SR Spellman WC Jean WA Hall WC Low (2001) ArticleTitleImmunization with dendritic cells pulsed with tumor extract increases survival of mice bearing intracranial glioma J Neuro-oncol 51 1–9 Occurrence Handle10.1023/A:1006452726391
SA Rosenberg (1999) ArticleTitleA new era for cancer immunotherapy based on the genes that encode cancer antigens Immunity 10 281–287 Occurrence Handle10.1016/S1074-7613(00)80028-X Occurrence Handle10204484
J Gong D Chen M Kashiwaba D Kufe (1997) ArticleTitleInduction of antitumor activity by immunization with fusion of dendritic cell and carcinoma cells Nat Med 3 558–561 Occurrence Handle10.1038/nm0597-558 Occurrence Handle9142127
KD Kim SC Choi A Kim YK Choe IS Choe JS Lim (2001) ArticleTitleDendritic cell-tumor coculturing vaccine can induce antitumor immunity through both NK and CTL interaction Int Immunopharmacol 1 2117–2129 Occurrence Handle10.1016/S1567-5769(01)00137-0 Occurrence Handle11710541
J Schmidt S Eisold MW Buchler A Marten (2004) ArticleTitleDendritic cells reduce number and function of CD4(+)CD25(+) cells in cytokine-induced killer cells derived from patients with pancreatic carcinoma Cancer Immunol Immunother 253 1018–1026
H Nishikawa T Kato K Tanida A Hiasa I Tawara H Ikeda Y Ikarashi H Wakasugi M Kronenberg T Nakayama M Taniguchi K Kuribayashi LJ Old H Shiku (2003) ArticleTitleCD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses Proc Natl Acad Sci USA 100 10902–10906 Occurrence Handle10.1073/pnas.1834479100 Occurrence Handle12947044
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vichchatorn, P., Wongkajornsilp, A., Petvises, S. et al. Dendritic Cells Pulsed with Total Tumor RNA for Activation NK-like T Cells Against Glioblastoma Multiforme. J Neurooncol 75, 111–118 (2005). https://doi.org/10.1007/s11060-005-2317-2
Issue Date:
DOI: https://doi.org/10.1007/s11060-005-2317-2